Basic FGF decreases clearance receptor of natriuretic peptides in fetoplacental artery endothelium

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Itoh, Hiroaki ^a,c   Zheng, Jing ^a   Bird, Ian M ^a   Nakao, Kazuwa ^c   Magness, Ronald R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial natriuretic peptide; Fibroblast growth factor; Mitogen activated protein kinase; Placenta; Pregnancy

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CYCLIC GMP; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; FETOPLACENTAL UNIT; HORMONE ACTION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0032830559     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.2.r541     Document Type: Article

References (35)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494, 1995.
2. Bird, I. M., J. Zheng, J. M. Cale, and R. R. Magness. Pregnancy induces an increase in angiotensin II type-1 receptor expression in uterine but not systemic artery endothelium. Endocrinology 138: 490-498, 1997.
3. Brandt, R. R., D. M. Heublein, L. L. Aarhus, J. A. Lewicki, and J. C. Burnett, Jr. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H326-H331, 1995.
4. Cale, J. M., C. E. Shaw, and I. M. Bird. Optimization of a reverse transcription/polymerase chain reaction (RT/PCR) mass assay for low abundance mRNA. In: Methods in Molecular Biology: Phospholipid Signaling Protocols, edited by I. M. Bird. Totowa, NJ: Humana, 1997, vol. 105, p. 351-371.
5. Cohen, D., G. Y. Koh, L. N. Nikonova, J. G. Porter, and T. Maack. Molecular determination of clearance function of type C receptor of natriuretic peptides. J. Biol. Chem. 271: 9863-9869, 1996.
6. Cooke, J. P., and P. S. Tsao. Endothelium-derived relaxing factor: an overview. In: Endocrinology of Vasculature, edited by J. R. Sowers. Totowa, NJ: Humana, 1996, p. 3-19.
7. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686-7689, 1995.
8. Fraenkel, M. B., G. P. Aldred, and J. G. McDougall. Sodium status affects GC-B natriuretic peptide receptor mRNA levels, but not GC-A or C receptor mRNA levels, in the sheep kidney. Clin. Sci. (Colch.) 86: 517-522, 1994.
9. Garbers, D. L., D. Koesling, and G. Schultz. Guanylate cyclase receptors. Mol. Biol. Cell 5: 1-5, 1994.
10. Hu, R. M., E. R. Levin, A. Pedram, and H. J. Frank. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J. Biol. Chem. 267: 17384-17389, 1992.
11. Itoh, H., I. M. Bird, K. Nakao, and R. R. Magness. Pregnancy increases soluble and particulate guanylate cyclases and decreases the clearance receptor of natriuretic peptides in ovine uterine but not systemic arteries. Endocrinology 138: 3329-3341, 1998.
12. Itoh, H., N. Sagawa, M. Hasegawa, T. Mori, S. Suga, M. Mukoyama, T. Yoshimasa, H. Itoh, and K. Nakao. Umbilical venous guanosine 3′,5′-cyclic phosphate (cGMP) concentration increases in asphyxiated newborns. Reprod. Fertil. Dev. 7: 1515-1519, 1995.
13. Itoh, H., N. Sagawa, M. Hasegawa, H. Nanno, Y. Ihara, F. Kobayashi, K. Kitagawa, T. Mori, S. Suga, T. Yoshimasa, H. Itoh, and H. Nakao. Expression of biologically active receptors for natriuretic peptides in the human uterus during pregnancy. Biochem. Biophys. Res. Commun. 203: 602-607, 1994.
14. Itoh, H., N. Sagawa, M. Hasegawa, A. Okagaki, K. Inamori, Y. Ihara, T. Mori, S. Suga, M. Mukoyama, G. Shirakami, K. Nakao, and H. Imura. Brain natriuretic peptide levels in the umbilical venous plasma are elevated in fetal distress. Biol. Neonate 64: 18-25, 1993.
15. Kishimoto, I., K. Nakao, S. Suga, K. Hosoda, T. Yoshimasa, H. Itoh, and H. Imura. Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1373-H1379, 1993.
16. 2-adrenergic stimulation in vascular smooth muscle cells. J. Biol. Chem. 269: 28300-28308, 1994.
17. Klinger, J. R., F. Arnal, R. R. Warburton, L. C. Ou, and N. S. Hill. Downregulation of pulmonary atrial natriuretic peptide receptors in rats exposed to chronic hypoxia. J. Appl. Physiol. 77: 1309-1316, 1994.
18. Li, H., S. Oparil, Q. C. Meng, T. S. Elton, and Y. F. Chen. Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L328-L335, 1995.
19. Maack, T. Role of atrial natriuretic factor in volume control. Kidney Int. 49: 1732-1737, 1996.
20. Magness, R. R., C. E. Shaw, T. Phernetton, J. Zheng, and I. M. Bird. Endothelial vasodilator production by uterine and systemic arteries: II. Pregnancy effects on NO synthase expression. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H1730-H1740, 1997.
21. Magness, R. R., and J. Zheng. Maternal cardiovascular alternation during pregnancy. In: Pediatrics and Perinatology; The Scientific Basis (2nd ed.), edited by P. D. Gluckman and M. A. Heymann. London: Arnold, 1996, p. 762-772.
22. Makowski, E. L., G. Meschia, W. Droegemueller, and F. C. Battaglia. Measurement of umbilical arterial blood flow to the sheep placenta and fetus in utero. Circ. Res. 23: 623-631, 1968.
23. Mukaddam-Daher, S., J. Gutkowska, J. Tremblay, T. V. Dam, and E. W. Quillen, Jr. Regulation of renal atrial natriuretic peptide receptor in pregnant sheep. Endocrinology 136: 4565-4571, 1995.
24. Nakao, K., Y. Ogawa, S. Suga, and H. Imuta. Molecular biology and biochemistry of the natriuretic peptide system II. Natriuretic peptide receptor. J. Hypertens. 10: 1111-1114, 1992.
25. Nakao, K., Y. Ogawa, S. Suga, and H. Imura. Molecular biology and biochemistry of the natriuretic peptide system I. Natriuretic peptides. J. Hypertens. 10: 907-912, 1992.
26. Prins, B. A., M. J. Weber, R. M. Hu, A. Pedram, M. Daniels, and E. R. Levin. Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation. J. Biol. Chem. 271: 14156-14162, 1996.
27. Rosenfeld, C. R., W. K. Samson, T. A. Roy, D. J. Faucher, and R. R. Magness. Vasoconstrictor-induced secretion of ANP in fetal sheep. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E526-E533, 1992.
28. Rudolph, A. M., and M. A. Heymann. Circulatory changes during growth in the fetal lamb. Circ. Res. 26: 289-299, 1970.
29. Sheppard, C., I. M. Bird, C. E. Shaw, and R. R. Magness. Third trimester increases in placental artery endothelial nitric oxide synthase correspond to amniotic fluid cGMP levels (Abstract). In: Proceedings of the Society for Gynecologic Investigation, March 19-23, 1996, Philadelphia, PA.
30. Suga, S., K. Nakao, K. Hosoda, M. Mukoyama, Y. Ogawa, G. Shirakami, H. Arai, Y. Saito, Y. Kambayashi, K. Inouye, and H. Imura. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239, 1992.
31. Suga, S., K. Nakao, I. Kishimoto, K. Hosoda, M. Mukoyama, H. Arai, G. Shirakami, Y. Ogawa, Y. Komatsu, O. Nakagawa, N. Hama, and H. Imura. Phenotype-related alternation in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ. Res. 71: 34-39, 1992.
32. Suga, S., K. Nakao, M. Mukoyama, H. Arai, K. Hosoda, Y. Ogawa, and H. Imura. Characterization of natriuretic peptide receptors in cultured cells. Hypertension 19: 762-765, 1992.
33. Zheng, J., I. M. Bird, A. N. Melsaether, and R. R. Magness. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140: 1399-1407, 1999.
34. Zheng, J., K. E. Vagnoni, I. M. Bird, and R. R. Magness. Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-1 receptors in the ovine placenta during the third trimester of pregnancy. Biol. Reprod. 56: 1189-1197, 1997.
35. Zheng, J., R. R. Magness, and I. M. Bird. A cell model for studying expression of feto-placental artery endothelial angiotensin II type-1 receptors and nitric oxide synthase. Med. Biochem. 1: 57-64, 1998.